Drug Database
Back to search

Belgium· BE-AMP-SAM069842-00

Rifocine 500 IV 500 mg

A rifamycin product containing rifamycin sodium, registered in Belgium by Sanofi Belgium.

ATC J04AB03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedRifocine 500 IV 500 mgATCJ04AB03REGISTER NO.BE-AMP-SAM069842-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about rifamycin sodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Rifamycin Sodium
Manufacturer
Sanofi Belgium
Country
Belgium (BE)
ATC code
J04AB03
ATC class
Rifamycin
Defined daily dose
0.6 g, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    0716522
  • be_apb
    0128165
    EUR 11.28

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for rifamycin.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check rifamycin against other medicinesHow interaction checks work

Rifamycin · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rifamycin in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rifamycin products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Bulgaria · Relafalk
  • Germany · Gutivia
  • Finland · Relafalk
  • France · Otofa, Rifamycine Chibret
  • Greece · Relafalk
  • Hungary · Relafalk
  • Italy · Dotecine, Rifocin
  • Luxembourg · Otofa, Rifocine I.V.
  • Norway · Relafalk
  • Poland · Relafalk
  • Portugal · Imfalda, Rifocina
  • Sweden · Relafalk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/678b3700-abc5-4936-8761-a0129d60b4a9
GET /v1/drugs/678b3700-abc5-4936-8761-a0129d60b4a9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Rifocine 500 IV 500 mg",
  "name_fr": "Rifocine 500 IV 500 mg",
  "name_nl": "Rifocine 500 IV 500 mg",
  "amp_code": "SAM069842-00",
  "strengths": [
    "50.0000",
    "3.0000",
    "9.6000",
    "1.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Rifamycin Sodium",
    "Rifamycin",
    "Propylene Glycol",
    "Sodium Hydrogen Carbonate",
    "Sodium Hydroxide",
    "Sodium Metabisulfite",
    "Sodium Edetate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Rifamycin",
  "authorisation_numbers": [
    "BE069842"
  ]
}
API referenceMCP serverPlans

See everything about rifamycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console